AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ

Posted by Owen Ajayi-Isaac

Date: December 11, 2015

Leave a comment

176 Views

Share this on WhatsApp

(Reuters) – British drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion, the Wall Street Journal reported, citing people familiar with the matter.

Source: ReuterBusiness

Share

Share this on WhatsApp

Related posts

• GE reopens parts of prior debt offerings to raise $3 billion

  June 08, 2020

• AstraZeneca contacted Gilead over potential megamerger: Bloomberg News

  June 07, 2020

• Lufthansa CEO promises Germans a 'homecoming guarantee'

  June 07, 2020

• BA, Ryanair, easyJet protest over 'wholly unjustified' UK quarantine plan

  June 07, 2020

• Emirates, Etihad extend temporary salary cuts to September

  June 07, 2020

• AstraZeneca approached Gilead about potential merger – Bloomberg News

  June 07, 2020

• Rosneft says no change to dividend policy despite lower state stake

  June 07, 2020

• HSBC warns it could face reprisals in China if UK bans Huawei equipment: Telegraph

  June 06, 2020

• Volkswagen considering more cost cuts to cope with downturn

  June 06, 2020

• Exclusive: Malaysia – Even $3 billion not enough to settle 1MDB case with Goldman

  June 06, 2020

• OPEC and allies to agree one-month extension to output cuts

  June 06, 2020

• Exclusive: Buyout firm Sycamore Partners in talks to buy J.C. Penney – sources

  June 06, 2020